Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Analysis of risk factors influencing acute graft rejection in allograft recipients

P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P Fiedor

Ann Transplant 2009; 14(1): 76-76 :: ID: 880480

Abstract

Background: Stability of graft function after allotransplantation is difficult to maintain. There are many factors that can worsen recipient's condition and may lead to acute graft rejection. The aim of this study was to evaluate the influence of various factors on the incidence of acute graft rejection episodes in patients after liver and kidney allotransplantation.
Material/Methods: 171 recipients after kidney and liver transplantation were
analyzed. Factors of interest included: immunosuppression patterns, existence of diabetes, received induction therapy, warm and cold ischemia time and acute rejection time. Next, the data of donors for the 171 patients was collected. All data was statistically analyzed.
Results: The number of kidney and liver recipients without acute graft rejection was the lowest for CsA and CellCept model compared to the highest for CsA and Aza model (p=0.0008). Tacrolimus causes the highest risk of induced diabetes after transplantation (p<0.001). The number of kidney and liver recipients with acute graft rejection was higher in patients who received graft from females comparing with the group who received grafts from males (p=0.0282). Every minute of warm ischemia time increases the risk of acute
graft rejection by 12.7%. The percentage of patients without AGR after 7 months with 2 common alleles, 1 common allele and 0 common alleles in HLA-DR was 100%, 55% and 30% respectively (p=0.0128).
Conclusions: The acute rejection time depends on many factors and how they affect graft stability was elucidated in this study.

Keywords: Immunosuppression, Kidney Transplantation, Liver Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358